119 related articles for article (PubMed ID: 19089842)
21. Characterization of Fe3O4/SiO2/Gd2O(CO3)2 core/shell/shell nanoparticles as T1 and T2 dual mode MRI contrast agent.
Yang M; Gao L; Liu K; Luo C; Wang Y; Yu L; Peng H; Zhang W
Talanta; 2015 Jan; 131():661-5. PubMed ID: 25281156
[TBL] [Abstract][Full Text] [Related]
22. Zinc ferrite nanoparticles as MRI contrast agents.
Bárcena C; Sra AK; Chaubey GS; Khemtong C; Liu JP; Gao J
Chem Commun (Camb); 2008 May; (19):2224-6. PubMed ID: 18463747
[TBL] [Abstract][Full Text] [Related]
23. Engineered core-shell magnetic nanoparticle for MR dual-modal tracking and safe magnetic manipulation of ependymal cells in live rodents.
Peng YK; Lui CNP; Chen YW; Chou SW; Chou PT; Yung KKL; Tsang SCE
Nanotechnology; 2018 Jan; 29(1):015102. PubMed ID: 29205171
[TBL] [Abstract][Full Text] [Related]
24. Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging.
Bomatí-Miguel O; Morales MP; Tartaj P; Ruiz-Cabello J; Bonville P; Santos M; Zhao X; Veintemillas-Verdaguer S
Biomaterials; 2005 Oct; 26(28):5695-703. PubMed ID: 15878375
[TBL] [Abstract][Full Text] [Related]
25. Mn(II) compounds as an alternative to Gd-based MRI probes.
Botta M; Carniato F; Esteban-Gómez D; Platas-Iglesias C; Tei L
Future Med Chem; 2019 Jun; 11(12):1461-1483. PubMed ID: 31298575
[TBL] [Abstract][Full Text] [Related]
26. Tunable Performance of Manganese Oxide Nanostructures as MRI Contrast Agents.
Bañobre-López M; García-Hevia L; Cerqueira MF; Rivadulla F; Gallo J
Chemistry; 2018 Jan; 24(6):1295-1303. PubMed ID: 29178467
[TBL] [Abstract][Full Text] [Related]
27. Fe(3)O(4)/MnO hybrid nanocrystals as a dual contrast agent for both T(1)- and T(2)-weighted liver MRI.
Im GH; Kim SM; Lee DG; Lee WJ; Lee JH; Lee IS
Biomaterials; 2013 Mar; 34(8):2069-76. PubMed ID: 23246062
[TBL] [Abstract][Full Text] [Related]
28. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma.
Lai J; Wang T; Wang H; Shi F; Gu W; Ye L
Mikrochim Acta; 2018 Apr; 185(4):244. PubMed ID: 29610993
[TBL] [Abstract][Full Text] [Related]
29. Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging.
Cui X; Belo S; Krüger D; Yan Y; de Rosales RT; Jauregui-Osoro M; Ye H; Su S; Mathe D; Kovács N; Horváth I; Semjeni M; Sunassee K; Szigeti K; Green MA; Blower PJ
Biomaterials; 2014 Jul; 35(22):5840-6. PubMed ID: 24768194
[TBL] [Abstract][Full Text] [Related]
30. Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging.
Jeon SL; Chae MK; Jang EJ; Lee C
Chemistry; 2013 Mar; 19(13):4217-22. PubMed ID: 23345158
[TBL] [Abstract][Full Text] [Related]
31. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
[TBL] [Abstract][Full Text] [Related]
32. Magnetic and fluorescent nanoparticles for multimodality imaging.
Mulder WJ; Griffioen AW; Strijkers GJ; Cormode DP; Nicolay K; Fayad ZA
Nanomedicine (Lond); 2007 Jun; 2(3):307-24. PubMed ID: 17716176
[TBL] [Abstract][Full Text] [Related]
33. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Prashant C; Dipak M; Yang CT; Chuang KH; Jun D; Feng SS
Biomaterials; 2010 Jul; 31(21):5588-97. PubMed ID: 20434210
[TBL] [Abstract][Full Text] [Related]
34. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
35. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
36. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.
Lee PW; Hsu SH; Wang JJ; Tsai JS; Lin KJ; Wey SP; Chen FR; Lai CH; Yen TC; Sung HW
Biomaterials; 2010 Feb; 31(6):1316-24. PubMed ID: 19959224
[TBL] [Abstract][Full Text] [Related]
37. How to quantify iron in an aqueous or biological matrix: a technical note.
Boutry S; Forge D; Burtea C; Mahieu I; Murariu O; Laurent S; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2009; 4(6):299-304. PubMed ID: 19998319
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology and MRI contrast enhancement.
Matson ML; Wilson LJ
Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177
[TBL] [Abstract][Full Text] [Related]
39. Assembly system of direct modified superparamagnetic iron oxide nanoparticles for target-specific MRI contrast agents.
Tanaka K; Kitamura N; Morita M; Inubushi T; Chujo Y
Bioorg Med Chem Lett; 2008 Oct; 18(20):5463-5. PubMed ID: 18829309
[TBL] [Abstract][Full Text] [Related]
40. Mn(II)-containing coordination nanoparticles as highly efficient T(1) contrast agents for magnetic resonance imaging.
Paul G; Prado Y; Dia N; Rivière E; Laurent S; Roch M; Elst LV; Muller RN; Sancey L; Perriat P; Tillement O; Mallah T; Catala L
Chem Commun (Camb); 2014 Jun; 50(51):6740-3. PubMed ID: 24829060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
